Welcome to the InfoSci Platform
East Coast Fever: Theileria Parva Infection of Cattle

East Coast Fever: Theileria Parva Infection of Cattle

Sammy Gichuhi Ndungu, Sebastian K. Waruri, James M. Wanjohi
Copyright: © 2021 |Pages: 26
ISBN13: 9781799864332|ISBN10: 1799864332|ISBN13 Softcover: 9781799864349|EISBN13: 9781799864356
DOI: 10.4018/978-1-7998-6433-2.ch009
Cite Chapter Cite Chapter

MLA

Ndungu, Sammy Gichuhi, et al. "East Coast Fever: Theileria Parva Infection of Cattle." Combating and Controlling Nagana and Tick-Borne Diseases in Livestock, edited by Caleb Oburu Orenge, IGI Global, 2021, pp. 195-220. https://doi.org/10.4018/978-1-7998-6433-2.ch009

APA

Ndungu, S. G., Waruri, S. K., & Wanjohi, J. M. (2021). East Coast Fever: Theileria Parva Infection of Cattle. In C. Orenge (Ed.), Combating and Controlling Nagana and Tick-Borne Diseases in Livestock (pp. 195-220). IGI Global. https://doi.org/10.4018/978-1-7998-6433-2.ch009

Chicago

Ndungu, Sammy Gichuhi, Sebastian K. Waruri, and James M. Wanjohi. "East Coast Fever: Theileria Parva Infection of Cattle." In Combating and Controlling Nagana and Tick-Borne Diseases in Livestock, edited by Caleb Oburu Orenge, 195-220. Hershey, PA: IGI Global, 2021. https://doi.org/10.4018/978-1-7998-6433-2.ch009

Export Reference

Mendeley
Favorite

Abstract

East coast fever, a disease of cattle caused by the protozoan parasite Theileria parva and transmitted by the three-host tick Rhipicephalus appendiculatus (the brown ear tick), is a major constraint to cattle production in Eastern, Central, and Southern Africa. In Kenya it is the most important tick-borne disease and a major constraint in cattle productivity. This is due to the high morbidity and mortality it causes in susceptible herds, the cost of control of the vector ticks, and the cost of treatment of clinical cases. Animals that recover from the disease also suffer from reduced productivity which can be long term. The limited distribution of the tick and the disease to only East, Central and Southern Africa also means that the market for therapeutic drugs and acaricides is small. Therefore, drug companies are not keen on funding research and development of new drug and acaricide molecules when resistance occurs.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.